Importance of ALK Testing
- Identifying patients eligible for targeted TKI therapy.
- Avoiding ineffective conventional chemotherapy in specific cases.
- Developing a personalized treatment plan based on tumor genetics.
Book ALK Gene Rearrangement Test in Saudi Arabia | Lahalak Medical Platform
ALK Gene Rearrangement testing is a critical diagnostic tool for lung cancer patients. It identifies genetic fusions, allowing clinicians to implement targeted TKI therapies that significantly improve patient survival rates and treatment quality.
Scientific name: ALK Gene Rearrangement Testing
A specialized laboratory test detecting ALK gene rearrangements in lung cancer cells via FISH or IHC. It identifies patients eligible for targeted Tyrosine Kinase Inhibitor (TKI) therapies for personalized oncology treatment.
Service type
Oncology Genetic Test
Duration
5-7 business days
Fasting
Fasting is not required
Included Services
- Sample collection or biopsy reception
- Tissue analysis via IHC or FISH
- Detailed medical result report
Medical Service Information
Target Groups
- Patients with Non-Small Cell Lung Cancer (NSCLC).
- Non-smokers diagnosed with lung adenocarcinoma.
- Patients showing resistance to standard treatments.
Understanding Results
- Positive Result: Confirms ALK rearrangement, indicating suitability for targeted inhibitors.
- Negative Result: No rearrangement detected; alternative therapies should be explored.
Conditions & Notices
- A recent tumor tissue biopsy must be provided
- Provide previous medical reports related to the condition
Medical services you might also like
